Allogene Therapeutics ALLO Q2 2025 earnings
Reported August 13, 2025 · Before market open
EPS estimate-$0.28
Next report
Aug 12, 2026 (in a month)Revenue estimate$2.2K
EPS estimate-$0.16
Financials
Q2 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Allogene Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Allogene Therapeutics report Q2 2025 earnings?
- Allogene Therapeutics (ALLO) reported Q2 2025 earnings on August 13, 2025 before market open.
- What were Allogene Therapeutics's Q2 2025 revenue and EPS?
- Allogene Therapeutics reported revenue of - and diluted EPS of $-0.23 for Q2 2025.
- Did Allogene Therapeutics beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-0.28 by $0.05.
- How did Allogene Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 28.1% from $-0.32.
- Where can I find Allogene Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001737287-25-000088) directly on SEC EDGAR. The filing index links above go to sec.gov.